MerLion Pharma
Latest round
- Series C
Last raised
- Oct 2010
Total raised
- $26M
Investors
- 10
About MerLion Pharma
Founded in 2002 and headquartered in Singapore, MerLion Pharma specializes in antibiotic development.05 mn. Founded by a team with a strong background in pharmaceuticals, MerLion has successfully completed five deals to date.MerLion Pharmaceuticals specializes in the development of innovative antibiotics, with a primary focus on its core product, Finafloxacin, a next-generation fluoroquinolone antibiotic. Finafloxacin has unique properties that make it one of the safest and fastest-acting antibiotics in its class. This drug has received regulatory approval from the US FDA and Health Canada for the treatment of acute otitis externa (ear infections), marketed under the brand name Xtoro™. In addition to ear infections, MerLion is advancing Finafloxacin for the treatment of complicated urinary tract infections (cUTIs), demonstrating efficacy through successful phase II clinical trials.70 from direct sales of its products, particularly Xtoro™, to hospitals and clinics. The company also engages in collaborations with defense agencies for further applications of Finafloxacin, contributing to its revenue through bulk purchase agreements with healthcare facilities and distributors.73 mn to expand its product line and enhance market penetration. The funds will support the launch of new applications for Finafloxacin beyond its current indications. Additionally, the company intends to target new markets in Europe and Asia by 2020, capitalizing on the increasing demand for effective antibiotic solutions. The strategic focus will also include bolstering collaborations with healthcare institutions to ensure wider accessibility to its antibiotic products, aligning with its commitment to address urgent healthcare challenges.
Who invested in MerLion Pharma
10 investors across 3 rounds
See all investors in MerLion Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MerLion Pharma
Who invested in MerLion Pharma?
MerLion Pharma has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MerLion Pharma raised?
MerLion Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did MerLion Pharma last raise money?
MerLion Pharma's most recent round on record is a Series C, in Oct 2010.
What does MerLion Pharma do?
Founded in 2002 and headquartered in Singapore, MerLion Pharma specializes in antibiotic development.
Where is MerLion Pharma headquartered?
MerLion Pharma is headquartered in Singapore, Singapore.
Which VCs invest in companies like MerLion Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at MerLion Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like MerLion Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.